Cancer-associated membrane protein as targeted therapy for bladder cancer

QR Code

Cancer-associated membrane protein as targeted therapy for bladder cancer

Bladder cancer (BC) recurrence is one of the primary clinical problems encountered by patients following chemotherapy. However, the mechanisms underlying their resistance to chemotherapy remain unclear. Alteration in the pattern of membrane proteins (MPs) is thought to be associated with this recurr...

Full description

Bibliographic Details
Main Authors:	Roslan, Adlina, Sulaiman, Nurshahira, Mohd Ghani, Khairul Asri, Nurdin, Armania
Format:	Article
Published:	MDPI 2022
Online Access:	http://psasir.upm.edu.my/id/eprint/100582/

Similar Items

Proteomic analysis of potential membrane proteins in bladder cancer
by: Roslan, Adlina
Published: (2022)

Hedgehog pathway proteins and their association with clinicopathological parameters of bladder cancer
by: Mohd Ariffin, Khairunnisa
Published: (2016)

The current status of checkpoint inhibitors in metastatic bladder cancer
by: Fahmy Ahmed, Omar Ahmed, et al.
Published: (2016)

Association of aromatase with bladder cancer stage and long-term survival: new insights into the hormonal paradigm in bladder cancer
by: Nguyen, Daniel P., et al.
Published: (2017)

Guillain-Barré Syndrome following intravesical Bacillus Calmette-Guérin therapy for bladder cancer: a rare and intriguing case report
by: Khor, Vincent, et al.
Published: (2024)

Identification and characterisation of flotillin-2 as a molecular target in breast and bladder cancers
by: Jafarzadeh, Narges
Published: (2013)

Photodynamic therapy: current trends and potential future role in the treatment of bladder cancer
by: Kochergin, Maxim, et al.
Published: (2024)

Tumor markers of bladder cancer : the schistosomal bladder tumors versus non-schistosomal bladder tumors.
by: Abdulamir, Ahmed Sahib, et al.
Published: (2009)

Cancer stem cell metabolism: A potential target for cancer therapy
by: Deshmukh, A., et al.
Published: (2016)

Current status of robotic assisted radical cystectomy with intracorporeal ileal neobladder for bladder cancer
by: Fahmy, Omar, et al.
Published: (2015)

Comprehending the pharmacological mechanism of marine phenolic acids in bladder cancer therapy against matrix metalloproteinase 9 protein by integrated network pharmacology and in-silico approaches
by: Roney, Miah, et al.
Published: (2024)

Prognostic impact of tumor-associated immune cell infiltrates at radical cystectomy for bladder cancer
by: Schubert, Tina, et al.
Published: (2019)

Pancreatic cancer treatment with targeted therapies: are we there yet
by: Nwaefulu, O. Ngozi, et al.
Published: (2022)

DNA repair in cancer: emerging targets for personalized therapy
by: Abbotts, Rachel, et al.
Published: (2014)

Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy
by: Min-Wen, J., et al.
Published: (2017)

Towards targeted cancer therapy: Aptamer or oncolytic virus?
by: Tan, K., et al.
Published: (2017)

Overexpression of CTAG1B is a potential biomarker in bladder cancer
by: Mansor, Siti Farizan, et al.
Published: (2014)

Effects of gamma-secretase inhibitor GSI-34 on bladder cancer cell viability, migration and notch-associated gene expression levels
by: Roslan, Nadzatul Nabila
Published: (2017)

Evaluation of OTX1 as a potential biomarker of bladder cancer
by: Baharudin, Aminuddin
Published: (2018)

Targeting transcription factor STAT3 for cancer prevention and therapy.
by: Chai, E., et al.
Published: (2015)

Advances in targeted and immunobased therapies for colorectal cancer in the genomic era
by: Heng, Fong Seow, et al.
Published: (2016)

Hedgehog signalling molecule, SMO is a poor prognostic marker in bladder cancer
by: Mohd Ariffin, Khairunnisa, et al.
Published: (2021)

Health-related quality of life after treatment for bladder cancer in England
by: Mason, Samantha J., et al.
Published: (2018)

Evaluation of CERS2 gene as a potential biomarker for bladder cancer
by: Aldoghachi, Ahmed Faris, et al.
Published: (2019)

Expression of notch signaling genes in putative bladder cancer stem cells
by: Thirumorthy, Arcana
Published: (2017)

Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)

Targeted therapy for cancer using pH-responsive nanocarrier systems
by: Manchun, S., et al.
Published: (2012)

Immunohistochemical analysis of homeobox protein expression in urothelial carcinoma of bladder
by: Md Akhir, Mohd Khairul Anuar
Published: (2016)

Investigation of dielectric properties of urine for pregnancy and bladder cancer detection / Zhu Chaozhe
by: Zhu , Chao Zhe
Published: (2020)

Phenotypic effects of in vitro miR-141 expression modulation in bladder cancer
by: Lai, Jiun Yee
Published: (2013)

Identification of Differentially Expressed Genes in Human Bladder Cancer using Oligonucleotide Microarray
by: Nik Hassan, Nik Norliza
Published: (2006)

Development of Cancer Immunotherapeutics Targeting Complement Regulatory Protein CD55
by: Bradley, Richard Grayson
Published: (2007)

Engineering apoferritin for targeted delivery of peptides or proteins for the treatment of breast cancer
by: Ferreira, Lenny
Published: (2023)

Ten years review of cancer bladder in Hospital Universiti Sains Malaysia, Kubang Kerian
by: Almotawakel, Ahmed Ali Abdullah
Published: (2006)

COX-2 inhibitors: a potential target for drug therapy in the management of colorectal cancer
by: Ryan, A R, et al.
Published: (1999)

Targeting ataxia telangiectasia-mutated and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized cancer therapy
by: Alsubhi, Nouf
Published: (2018)

Analysis of PPI networks of transcriptomic expression identifies hub genes associated with Newcastle disease virus persistent infection in bladder cancer
by: Ahmad, Umar, et al.
Published: (2023)

Persistent Newcastle disease virus infection in bladder cancer cells is associated with putative pro-survival and anti-viral transcriptomic changes
by: Chan, Lee Chin, et al.
Published: (2021)

Pluronic F-127 Coated Zinc Oxide Nanoparticles Cytotoxicity And Their Photodynamic Therapy Towards Human Rt4 Urinary Bladder Cancer Cell Lines
by: Soud Abuelsamen, Abdulsalam Ali
Published: (2019)

Bioassay-guided isolation of triterpene compounds from Dillenia suffruticosa and their cytotoxic activities against cancer cells
by: Armania Nurdin,, et al.
Published: (2022)